# Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT

> **NCT01724619** · EARLY_PHASE1 · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 7 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** [F-18] fluorinated dihydrotestosterone (FDHT)

## Key facts

- **NCT ID:** NCT01724619
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Study tracer can no longer be obtained at our institution
- **Last updated:** 2018-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01724619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01724619, "Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01724619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*